Simultaneous presence of unsaturation and long alkyl chain at <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" altimg="si10.gif" overflow="scroll"><mml:mrow><mml:msubsup><mml:mrow><mml:mtext>P</mml:mtext></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mo>′</mml:mo></mml:mrow></mml:msubsup></mml:mrow></mml:math> of Ilomastat confers selectivity for gelatinase A (MMP-2) over gelatinase B (MMP-9) inhibition as shown by molecular modelling studies
作者:Gautier Moroy、Clément Denhez、Haquima El Mourabit、Alix Toribio、Alexandra Dassonville、Martine Decarme、Jean-Hugues Renault、Catherine Mirand、Georges Bellon、Janos Sapi、Alain J.P. Alix、William Hornebeck、Erika Bourguet
DOI:10.1016/j.bmc.2007.05.001
日期:2007.7
Structural analogues of Ilomastat (Galardin (R)), containing unsaturation(s) and chain extension carrying bulky phenyl group or alkyl moieties at P-1(') were synthesized and purified by centrifugal partition chromatography. They were analyzed for their inhibitory capacity towards MMP-1, MMP-2, MMP-3, MMP-9 and MMP-14, main endopeptidases involved in tumour progression. Presence of unsaturation(s) decreased the inhibitory potency of compounds but, in turn increased their selectivity for gelatinases. 2b and 2d derivatives with a phenyl group inhibited preferentially MMP-9 with IC50 equal to 45 and 38 nM, respectively, but also display activity against MMP-2 IC50 equal to 280 and 120 nM, respectively). Molecular docking computations confirmed affinity of these substances for both gelatinases. With aims to obtain a specific gelatinase A (MMP-2) inhibitor, P, of Ilomastat was modified to carry one unsaturation coupled to an alkyl chain with pentylidene group. Docking studies indicated that MMP-2, but not MMP-9, could accommodate such substitution; indeed 2a proved to inhibit MMP-2 (IC50 = 123 nM), while displaying no inhibitory capacity towards MMP-9. (c) 2007 Elsevier Ltd. All rights reserved.